A powerful tool for the final treatment of some benign and malignant tumors of the lungs, liver, kidneys, bone, and soft tissues as well as for pain relief is the development of imaging devices and modalities over the past two decades. One such technique is tumor ablation. One of the minimally invasive procedures used to eliminate cancerous cells in the patient's liver, chest, and other organs is tumor ablation. The main contributor to the rise in cancer cases is the shift in lifestyle and unhealthy eating patterns, as well as rising tobacco and alcohol use. In 2016, the National Cancer Institute (NCI) reported that 1,685,210 new cases of cancer were discovered in the United States.
The
Tumor Ablation Devices Market is expanding as a result of technological
developments in the field of tumor ablation combined with improved procedural
safety profiles, rising market demand for minimally invasive tumor ablation
techniques, rising cancer prevalence worldwide, and an increase in
public-private initiatives and funding to support ongoing research activities
related to tumor ablation. The best possible market growth, however, is being
constrained by elements like unfavorable regulatory policies and
cost-containment measures implemented by various governments.
Devices
for bone Tumor Ablation Devices Market are being widely
used by numerous surgeons to treat bone cancer. Additionally, the need for an
efficient yet safe therapy to treat bone tumors is anticipated to spur revenue
growth in the market for bone tumor ablation devices. Another factor driving
the expansion of the global market for Tumor
Ablation Devices Market is the growing elderly population, which
is more susceptible to disease. Over the forecast period, the demand for bone
tumor ablation devices is anticipated to increase due to the growing
preference of surgeons and older patients for minimally invasive procedures due
to the advantages such as quicker recovery, patient comfort, and shorter
turnaround times.
Key players
Boston Scientific
Corporation, Medtronic Plc, Intuitive Surgical, Inc., Johnson & Johnson,
Smith & Nephew Plc., Angiodynamics, HealthTronics, Inc., SonaCare Medical,
LLC, Galil Medical Inc., EDAP TMS S.A., Abbott Laboratories, NuVasive, Inc.,
and Opinion Medical Systems Co., Ltd. are the major companies competing in the
global market for tumor ablation devices
Comments
Post a Comment